Lei Wan

664 total citations
28 papers, 496 citations indexed

About

Lei Wan is a scholar working on Cancer Research, Molecular Biology and Surgery. According to data from OpenAlex, Lei Wan has authored 28 papers receiving a total of 496 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cancer Research, 8 papers in Molecular Biology and 6 papers in Surgery. Recurrent topics in Lei Wan's work include MicroRNA in disease regulation (5 papers), Antioxidant Activity and Oxidative Stress (5 papers) and Cancer-related molecular mechanisms research (3 papers). Lei Wan is often cited by papers focused on MicroRNA in disease regulation (5 papers), Antioxidant Activity and Oxidative Stress (5 papers) and Cancer-related molecular mechanisms research (3 papers). Lei Wan collaborates with scholars based in China, United States and Australia. Lei Wan's co-authors include Jennifer M. Thomas‐Ahner, Steven K. Clinton, John W. Erdman, Nancy E. Moran, David M. Francis, Steven J. Schwartz, Elizabeth M. Grainger, Zhongjun Wu, Dennis K. Pearl and Zhongtang Li and has published in prestigious journals such as Cancer Research, Scientific Reports and Journal of Nutrition.

In The Last Decade

Lei Wan

28 papers receiving 489 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lei Wan China 13 188 122 89 61 59 28 496
Teresa Rossi Italy 12 255 1.4× 117 1.0× 95 1.1× 78 1.3× 61 1.0× 28 564
Birdal Bilir United States 11 297 1.6× 107 0.9× 84 0.9× 75 1.2× 24 0.4× 16 584
Liping Xie China 13 399 2.1× 161 1.3× 79 0.9× 59 1.0× 35 0.6× 37 637
Pelin Telkoparan‐Akillilar Türkiye 13 440 2.3× 94 0.8× 34 0.4× 49 0.8× 44 0.7× 30 686
Steven K. Huan Taiwan 9 289 1.5× 51 0.4× 46 0.5× 53 0.9× 75 1.3× 15 463
María Eugenia Pasqualini Argentina 11 182 1.0× 155 1.3× 26 0.3× 38 0.6× 31 0.5× 29 461
Tseng‐Hsi Lin Taiwan 13 187 1.0× 58 0.5× 40 0.4× 82 1.3× 25 0.4× 19 480
Jin-Ming Hwang Taiwan 15 322 1.7× 88 0.7× 38 0.4× 57 0.9× 26 0.4× 20 588
Navin Rauniyar United States 11 498 2.6× 68 0.6× 51 0.6× 49 0.8× 34 0.6× 24 714
Xinxing Li China 15 264 1.4× 92 0.8× 21 0.2× 141 2.3× 91 1.5× 31 561

Countries citing papers authored by Lei Wan

Since Specialization
Citations

This map shows the geographic impact of Lei Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lei Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lei Wan more than expected).

Fields of papers citing papers by Lei Wan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lei Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lei Wan. The network helps show where Lei Wan may publish in the future.

Co-authorship network of co-authors of Lei Wan

This figure shows the co-authorship network connecting the top 25 collaborators of Lei Wan. A scholar is included among the top collaborators of Lei Wan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lei Wan. Lei Wan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wen, Hao, et al.. (2025). Metabolic alterations driven by LDHA in CD8 + T cells promote immune evasion and therapy resistance in NSCLC. Scientific Reports. 15(1). 24440–24440. 1 indexed citations
2.
Wan, Lei, et al.. (2025). Optimal sizing and operation of community hybrid energy storage systems. Journal of Energy Storage. 119. 116209–116209. 2 indexed citations
3.
Su, Rui, Lei Wan, Junliang Pu, et al.. (2025). Safety, tolerability, pharmacokinetics and pharmacodynamics of GZR4 , a novel once‐weekly basal insulin, in healthy participants: A randomized trial. Diabetes Obesity and Metabolism. 27(5). 2515–2522. 1 indexed citations
4.
Zhang, Ting, et al.. (2023). Safety, tolerability, and pharmacokinetics of oral (S)-oxiracetam in Chinese healthy volunteers: A randomized, double-blind, controlled phase I study. European Journal of Pharmaceutical Sciences. 192. 106621–106621. 2 indexed citations
5.
Wan, Lei, Jennifer M. Thomas‐Ahner, Dennis K. Pearl, et al.. (2023). Orchestration of miRNA Patterns by Testosterone and Dietary Tomato Carotenoids during Early Prostate Carcinogenesis in TRAMP Mice. Journal of Nutrition. 153(7). 1877–1888. 1 indexed citations
6.
Moran, Nancy E., Jennifer M. Thomas‐Ahner, Lei Wan, et al.. (2022). Tomatoes, Lycopene, and Prostate Cancer: What Have We Learned from Experimental Models?. Journal of Nutrition. 152(6). 1381–1403. 30 indexed citations
7.
Zhou, Feng, et al.. (2021). MicroRNA-126a-5p Exerts Neuroprotective Effects on Ischemic Stroke via Targeting NADPH Oxidase 2. Neuropsychiatric Disease and Treatment. Volume 17. 2089–2103. 14 indexed citations
8.
Huang, Zuotian, Tong Mou, Yunhai Luo, et al.. (2020). Inhibition of miR-450b-5p ameliorates hepatic ischemia/reperfusion injury via targeting CRYAB. Cell Death and Disease. 11(6). 455–455. 78 indexed citations
9.
Decker, Joseph T., et al.. (2020). Cyclin E overexpression confers resistance to trastuzumab through noncanonical phosphorylation of SMAD3 in HER2+ breast cancer. Cancer Biology & Therapy. 21(11). 994–1004. 10 indexed citations
10.
Ji, Bingyuan, et al.. (2020). Roles for heterodimerization of APJ and B2R in promoting cell proliferation via ERK1/2-eNOS signaling pathway. Cellular Signalling. 73. 109671–109671. 14 indexed citations
11.
Zhou, Zhuang, et al.. (2018). Dexmedetomidine protects hepatic cells against oxygen‐glucose deprivation/reperfusion injury via lncRNA CCAT1. Cell Biology International. 42(9). 1250–1258. 8 indexed citations
12.
Grainger, Elizabeth M., Nancy E. Moran, David M. Francis, et al.. (2018). A Novel Tomato-Soy Juice Induces a Dose-Response Increase in Urinary and Plasma Phytochemical Biomarkers in Men with Prostate Cancer. Journal of Nutrition. 149(1). 26–35. 27 indexed citations
13.
Rao, Shreyas S., Jenna R. Stoehr, Danijela Đokić, et al.. (2017). Synergistic effect of eribulin and CDK inhibition for the treatment of triple negative breast cancer. Oncotarget. 8(48). 83925–83939. 41 indexed citations
14.
Cichon, Morgan J., Kenneth M. Riedl, Lei Wan, et al.. (2017). Plasma Metabolomics Reveals Steroidal Alkaloids as Novel Biomarkers of Tomato Intake in Mice. Molecular Nutrition & Food Research. 61(12). 12 indexed citations
15.
Zhang, Xiaojun, et al.. (2015). [Relations of synovial angiogenesis and PTEN/PI3K/AKT signaling pathway in rats with adjuvant arthritis].. PubMed. 28(1). 71–4. 3 indexed citations
16.
Wan, Lei, Jennifer M. Thomas‐Ahner, Dennis K. Pearl, et al.. (2014). Dietary Tomato and Lycopene Impact Androgen Signaling- and Carcinogenesis-Related Gene Expression during Early TRAMP Prostate Carcinogenesis. Cancer Prevention Research. 7(12). 1228–1239. 55 indexed citations
17.
Zhang, Chaonan, et al.. (2014). [Effect of electroacupuncture intervention on renal function and expression of renal beta-catenin in rats with chronic renal failure].. PubMed. 39(5). 396–400. 2 indexed citations
18.
Zhang, Chaonan, et al.. (2014). [Observation on therapeutic effects of acupoint injection of metoclopramide for postsurgical gastroparesis syndrome].. PubMed. 39(5). 406–9. 2 indexed citations
19.
Thomas‐Ahner, Jennifer M., Elizabeth M. Grainger, Lei Wan, et al.. (2010). Tomato-based food products for prostate cancer prevention: what have we learned?. Cancer and Metastasis Reviews. 29(3). 553–568. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026